Top Research Reports For Alibaba, Roche & Intel
Zacks Investment Research | Mar 12, 2020 02:33AM ET
Thursday, March 12, 2020
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 12 major stocks, including Alibaba (NYSE:BABA) Group (BABA), Roche Holding (SIX:ROG) (RHHBY) and Intel (INTC). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see
Alibaba’s shares have outperformed the Zacks Internet Commerce industry over the past six months (+5.1% vs. -0.2%). The Zacks analyst believes that Alibaba’s higher costs associated with new initiatives remain a major concern. Also, uncertain economy and macro headwinds in China are major concerns.
In addition, rising competition from e-commerce players poses a risk. However, the steady improvement in core commerce and strong cloud business remain positives. The company continues to benefit from strong growth in metrics. Further, Alibaba’s strengthening cloud business with its expanding customer base continues to drive its performance.
Its New Retail strategy is also gaining momentum. This is aiding growth in Tmall Import, Hema fresh food grocery business and Intime Department Stores.
(You can )
Shares of Roche have gained +7.8% over the past year against the Zacks Large Cap Pharmaceuticals industry’s fall of -3.2%. The Zacks analyst believes that Roche’s performance has been impressive, propelled by solid sales of new drugs.
Strong growth of Ocrevus, Perjeta, Tecentriq and Hemlibra countered biosimilar competition for Herceptin, MabThera and Avastin. Particularly, MS drug Ocrevus witnessed strong growth on increased demand. Roche’s dominant position in the breast cancer space continues to boost performance on label expansion of drugs. Also, label expansion of blockbuster immune-oncology drug Tecentriq into additional indications is a positive.
The recent Spark acquisition will boost Roche’s presence in the gene therapy space as well. However, most of the legacy drugs are facing biosimilar competition. Additionally, pipeline setbacks are concerns as well.
Get The News You Want
(You can )
Intel’s shares have lost -16.2% over the past three months against the Zacks General Semiconductor industry’s fall of -6.6%. The Zacks analyst believes that Intel is benefiting from strong data-centric growth. Robust mix of high-performance 2nd-Gen Xeon Scalable processors and solid demand from Cloud service providers is expected to drive near-term growth.
The company is also making advancements in the IoT space, courtesy of product introductions and tie ups. Moreover, Intel is witnessing strong momentum for its first 10-nanometer (nm) mobile CPU. The company is planning nine product releases on 10 nm this year.
Further, it is adding 25% wafer capacity across its 14 nm and 10 nm nodes in 2020. Nevertheless, declining PC total addressable market, higher expenses pertaining to 10-nm ramp up and constrained supply amid coronavirus outbreak in China remain concerns.
(You can )
Other noteworthy reports we are featuring today include Welltower (WELL), Tyson Foods (NYSE:TSN) (TSN) and Canadian Natural Resources (CNQ).
The Hottest Tech Mega-Trend of All
Last year, it generated $24 billion in global revenues. By 2020, it's predicted to blast through the roof to $77.6 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
See Zacks' 3 Best Stocks to Play This Trend >>
Mark Vickery
Senior Editor
Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly
Today's Must Read/h6
Featured Reports/h6
Per the Zacks analyst, Welltower's portfolio-realignment moves will likely drive long-term sustainability as well as cash flow.
Per the Zacks analyst, Tyson Foods is likely to gain from Financial Fitness Program, which aims at enhancing operational efficiency.
The Zacks analyst is impressed by Canadian Natural's growing free cash flow but is worried about the C$3.25-billion term loan that will worsen its balance sheet.
The Zacks analyst is appreciative of the company's efforts to expand its fleet. Initiatives to extend its presence apart from adding shareholder value are encouraging too.
Per the Zacks Analyst, AES Corp.'s focus on renewables should boost growth led by rapid expansion of renewable overseas footprint.
Perrigo's restructuring initiatives will generate millions in annual savings, however, the Zacks Analyst is concerned about stiff competition.
Per the Zacks analyst, People's United's strong liquidity position makes it well poised to grow through acquisitions.
Per the Zacks analyst, Welltower's portfolio-realignment moves will likely drive long-term sustainability as well as cash flow.
Per the Zacks analyst, Tyson Foods is likely to gain from Financial Fitness Program, which aims at enhancing operational efficiency.
The Zacks analyst is impressed by Canadian Natural's growing free cash flow but is worried about the C$3.25-billion term loan that will worsen its balance sheet.
The Zacks analyst is appreciative of the company's efforts to expand its fleet. Initiatives to extend its presence apart from adding shareholder value are encouraging too.
Per the Zacks Analyst, AES Corp.'s focus on renewables should boost growth led by rapid expansion of renewable overseas footprint.
Perrigo's restructuring initiatives will generate millions in annual savings, however, the Zacks Analyst is concerned about stiff competition.
Per the Zacks analyst, People's United's strong liquidity position makes it well poised to grow through acquisitions.
New Upgrades/h6
Per the Zacks analyst, rise in passenger revenues (up 3.4% in 2019) and efforts to check non-fuel unit costs are driving the carrier's growth.
The Zacks analyst is impressed with the lease fleet growth at Trinity (TRN). Efforts to reward its shareholders through dividends and buybacks are also promising.
The Zacks analyst believes that the Sandbox and EP Minerals buyouts will support U.S. Silica's margins. The company will also likely gain from expansion actions in the Permian Basin.
Per the Zacks analyst, rise in passenger revenues (up 3.4% in 2019) and efforts to check non-fuel unit costs are driving the carrier's growth.
The Zacks analyst is impressed with the lease fleet growth at Trinity (TRN). Efforts to reward its shareholders through dividends and buybacks are also promising.
The Zacks analyst believes that the Sandbox and EP Minerals buyouts will support U.S. Silica's margins. The company will also likely gain from expansion actions in the Permian Basin.
New Downgrades/h6
Per the Zacks analyst, Flex's substantial China exposure amid coronavirus crisis is likely to weigh on near-term financial performance.
Per the Zacks Analyst, mounting expenses due to Synovus' investments in infrastructure and technology remains a major headwind. Also, exposure to commercial real estate loans keeps us apprehensive.
Per the Zacks analyst, lower demand for high-value products will weigh on the company's Flat-Rolled Products (FRP) segment. Its high debt level is another concern.
Per the Zacks analyst, Flex's substantial China exposure amid coronavirus crisis is likely to weigh on near-term financial performance.
Per the Zacks Analyst, mounting expenses due to Synovus' investments in infrastructure and technology remains a major headwind. Also, exposure to commercial real estate loans keeps us apprehensive.
Per the Zacks analyst, lower demand for high-value products will weigh on the company's Flat-Rolled Products (FRP) segment. Its high debt level is another concern.
undefined Zacks Investment Research
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.